United States
Germany
Japan
United Kingdom
China
CNY 2,700.00
CNY 3,790.00
2周
KRT20 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
Products
Lenti ORF clone of Human keratin 20 (KRT20), mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
Lenti ORF clone of Human keratin 20 (KRT20), Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
KRT20 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Cytokeratin 7 (KRT7) mouse monoclonal antibody, clone OVTL-12/30, Supernatant
| Applications | IF, IHC, WB |
| Reactivities | Human |
Cytokeratin 5 (KRT5) mouse monoclonal antibody, clone D5/16 B4, Supernatant
| Applications | IHC |
| Reactivities | Human |
KRT20 (Keratin 20) mouse monoclonal antibody, clone OTI6D5 (formerly 6D5)
| Applications | WB |
| Reactivities | Human |
KRT20 (Keratin 20) mouse monoclonal antibody, clone OTI3A5 (formerly 3A5)
| Applications | WB |
| Reactivities | Human |
KRT20 mouse monoclonal antibody, clone OTI5A2 (formerly 5A2)
| Applications | WB |
| Reactivities | Human |
KRT20 mouse monoclonal antibody, clone OTI5F1 (formerly 5F1)
| Applications | WB |
| Reactivities | Human |
CNY 2,700.00
CNY 3,790.00
2周
KRT20 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
CNY 2,600.00
CNY 3,600.00
现货
KRT20 mouse monoclonal capture antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
CNY 2,600.00
CNY 3,600.00
现货
KRT20 mouse monoclonal capture antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
Rabbit Polyclonal Anti-Keratin 20 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRT20 mouse monoclonal antibody, clone OTI6B9 (formerly 6B9)
| Applications | WB |
| Reactivities | Human |
